Status:
NOT_YET_RECRUITING
Knee Prosthetic Joint Infection Antibiotic Elution
Lead Sponsor:
University of Pittsburgh
Conditions:
Prosthetic-joint Infection
Arthroplasty Complications
Eligibility:
All Genders
18+ years
Brief Summary
Patients presenting with prosthetic joint infections of a total knee replacement who are treated with an antibiotic spacer will be observed prospectively for their response to treatment and antibiotic...
Detailed Description
The current study aims to assess the surgical and patient-reported outcomes and in vivo antibiotic elution profile of the management of total knee arthroplasty (TKA) prosthetic joint infection (PJI). ...
Eligibility Criteria
Inclusion
- Patients planned for treatment of a total knee arthroplasty prosthetic joint infection
- Patients greater than 18 years of age
- Patients able to provide informed consent
Exclusion
- Prior history of ipsilateral or contralateral prosthetic joint infection warranting operative management
- Patients less than 18 years of age
- Patients unable to provide informed consent.
Key Trial Info
Start Date :
January 5 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06023238
Start Date
January 5 2026
End Date
December 31 2029
Last Update
October 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC Shadyside
Pittsburgh, Pennsylvania, United States, 15232